CTOs on the Move

Shifamed

www.shifamed.com

 
Shifamed is a Campbell, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.shifamed.com
  • 746 Camden Ave Suite A
    Campbell, CA USA 95008
  • Phone: 408.903.4090

Executives

Name Title Contact Details

Similar Companies

Advanced Health and Wellness

Advanced Health and Wellness is a Fargo, ND-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Geonetric

Geonetric is a Cedar Rapids, IA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Southern Oregon Orthopedics Inc

The physicians of Southern Oregon Orthopedics, Inc. have been providing the residents of Southern Oregon and Northern California with high quality orthopedic care for the past 50 years. Our physicians are active staff members at Rogue Valley Medical

nu ear electronics

nu ear electronics is a Eden Prairie, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Sernova

Sernova Corp. is a clinical-stage biotechnology company that is developing its Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells, for the treatment of chronic diseases such as insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. On implantation, the Cell Pouch forms a natural vascularized tissue environment in the body for the long-term survival and function of therapeutic cells that release essential factors absent or deficient in patients with certain chronic diseases. Sernova is also advancing a proprietary technology to shield therapeutic cells from immune system attacks with the goal to eliminate the need for chronic, systemic immunosuppression. In May 2022, the Company announced a global strategic partnership with Evotec, providing Sernova with a potentially unlimited supply of insulin-producing islet cells to treat patients with insulin-dependent diabetes (type 1 and type 2). Sernova continues to progress additional development programs utilizing its Cell Pouch System: a cell therapy for hypothyroid disease resulting from thyroid gland removal and an ex-vivo lentiviral Factor VIII gene therapy for hemophilia A.